{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T14:29:23Z","timestamp":1700404163375},"reference-count":62,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"vor","delay-in-days":3173,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Viral hepatitis, particularly that due to HBV or HCV, is a significant problem in the UK population of IVDUs and alcohol misusers. Patients attending drug rehabilitation clinics should be screened for HBV and HCV infection. All those found to be HBcAb negative should be vaccinated against HBV. Those found to be HBsAg or HCV antibody positive should have their liver function tests (LFTs) checked and be referred to a specialist liver clinic for further evaluation. Interferon treatment of HBV or HCV infection is effective in a proportion of cases but it is an expensive agent that requires careful monitoring. Current management regimes are centred around the modification of risk behaviour and the identification of those most in need of, and most likely to respond to, anti\u2010viral treatment. Several new anti\u2010viral agents are currently undergoing clinical evaluation and this together with the prospect of vaccines designed to clear an established infection means that the next few years are likely to see some major advances in the treatment of chronic viral hepatitis.<\/jats:p>","DOI":"10.1080\/13556219772462","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:11:58Z","timestamp":1027699918000},"page":"411-420","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatitis in alcohol and drug misusers: practical issues"],"prefix":"10.1111","volume":"2","author":[{"given":"MATTHEW E.","family":"CRAMP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROGER","family":"WILLIAMS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"1983\u20131994 by specimen year. Data to 31\/5\/95","author":"Laboratory reports of hepatitis A virus infections to PHLS CDSC England and Wales","year":"1995"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-10-838"},{"key":"e_1_2_1_4_2","first-page":"4","article-title":"Risk factors for severe hepatitis A virus infection","volume":"12","author":"O'Grady JG.","year":"1995","journal-title":"Hepatocite"},{"key":"e_1_2_1_5_2","first-page":"237","article-title":"Increasing age\u2014an important adverse prognostic factor in hepatitis A virus infection","volume":"22","author":"Forbes A","year":"1988","journal-title":"J R Coll Physicians Lond"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890440426"},{"key":"e_1_2_1_7_2","volume-title":"Incidence and prevalence rates in the UK. Hepatitis B in the UK; 1986","author":"Short R","year":"1986"},{"key":"e_1_2_1_8_2","first-page":"641","article-title":"Frequency of asymptomatic hepatitis types B and C in an inner city community and relation to possible risk factors","volume":"80","author":"King R","year":"1991","journal-title":"Q J Med"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1996.911014575.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6975.285"},{"key":"e_1_2_1_11_2","volume-title":"Sexual attitudes and lifestyles","author":"Johnson AM","year":"1994"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6899.276"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7077.329"},{"key":"e_1_2_1_14_2","volume-title":"Laboratory reports of acute HBV infections to PHLS CDSC England and Wales","year":"1995"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7042.1336"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1990.tb01656.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7018.1500"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-4-199308150-00011"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605303342202"},{"key":"e_1_2_1_20_2","first-page":"1321","article-title":"Type D (delta) hepatitis [clinical conference] [published erratum appears in JAMA 37. 1989 Jun 23\u201330;261:3552]","volume":"261","author":"Hoofnagle JH.","year":"1989","journal-title":"JAMA"},{"key":"e_1_2_1_21_2","first-page":"299","volume-title":"Hepatitis delta virus and its infection","author":"Rosina F","year":"1987"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007259"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90293-3"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007262"},{"key":"e_1_2_1_25_2","first-page":"S41","article-title":"Hepatitis C virus genetic variability: clinical implication","volume":"89","author":"Brechot C.","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(95)95114-8"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92300-I"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91992-9"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.4.768"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342602"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403173301103"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890410309"},{"key":"e_1_2_1_33_2","volume-title":"Hepatitis C and drug addiction in France, epidemiology and therapeutic consequences","year":"1996"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199507000-00005"},{"key":"e_1_2_1_35_2","volume-title":"The prevalence and management of hepatitis C in injecting drug users attending drug services in the United Kingdom","author":"Waller TAN","year":"1995"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007264"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-5-199509010-00002"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/hep.1840140603","article-title":"Long\u2010term clinical and histopathological follow\u2010up of chronic post\u2010transfusion hepatitis","volume":"14","author":"Bisceglie AM","year":"1991","journal-title":"Hepatology"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-6-443"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07642-8"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506013322202"},{"key":"e_1_2_1_42_2","first-page":"399","article-title":"Clinical sequelae of hepatitis C acquired from injection drug use","volume":"164","author":"Tong MJ","year":"1996","journal-title":"West J Med"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180609"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08312.x"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212313272703"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007267"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200503"},{"key":"e_1_2_1_48_2","first-page":"39","article-title":"Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C","volume":"88","author":"Yamauchi M","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_49_2","first-page":"1022","article-title":"Epidemiology of hepatitis C among veterans with alcoholic liver disease","volume":"88","author":"Mendenhall CL","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606063342310"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601183340316"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703133361101"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703133361109"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506013322211"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240405"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007265"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150607"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.4.449"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91739-X"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199457120-00003"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512213332501"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-12-199512150-00001"},{"issue":"2","key":"e_1_2_1_63_2","first-page":"8","article-title":"The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C","volume":"23","author":"Chemello L","year":"1995","journal-title":"J Hepatol"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F13556219772462","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/13556219772462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T19:58:27Z","timestamp":1698436707000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1080\/13556219772462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1080\/13556219772462"],"URL":"https:\/\/doi.org\/10.1080\/13556219772462","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]},"assertion":[{"value":"2006-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}